MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $17,413,983 | -55.1% | 8,663,673 | 0.0% | 1.91% | -38.7% |
Q1 2024 | $38,813,255 | +93.1% | 8,663,673 | 0.0% | 3.12% | +61.9% |
Q4 2023 | $20,099,721 | +82.7% | 8,663,673 | 0.0% | 1.93% | +56.7% |
Q3 2023 | $11,002,865 | -61.4% | 8,663,673 | 0.0% | 1.23% | -58.1% |
Q2 2023 | $28,503,484 | +79948.0% | 8,663,673 | 0.0% | 2.94% | -34.0% |
Q1 2023 | $35,608 | -29.9% | 8,663,673 | 0.0% | 4.45% | -21.6% |
Q4 2022 | $50,769 | -99.9% | 8,663,673 | 0.0% | 5.67% | -18.9% |
Q3 2022 | $58,566,000 | +46.3% | 8,663,673 | 0.0% | 6.99% | +48.9% |
Q2 2022 | $40,026,000 | +53.8% | 8,663,673 | +32.8% | 4.69% | +85.8% |
Q1 2022 | $26,023,000 | -22.3% | 6,522,030 | +21.1% | 2.53% | -4.9% |
Q4 2021 | $33,499,000 | -3.9% | 5,385,667 | +45.7% | 2.66% | +22.9% |
Q3 2021 | $34,850,000 | -30.6% | 3,695,667 | 0.0% | 2.16% | -34.2% |
Q2 2021 | $50,187,000 | -16.1% | 3,695,667 | 0.0% | 3.29% | -2.9% |
Q1 2021 | $59,796,000 | -34.8% | 3,695,667 | +7.3% | 3.39% | -41.2% |
Q4 2020 | $91,689,000 | +42.9% | 3,445,667 | 0.0% | 5.76% | -3.7% |
Q3 2020 | $64,158,000 | -20.4% | 3,445,667 | 0.0% | 5.98% | -29.2% |
Q2 2020 | $80,629,000 | – | 3,445,667 | – | 8.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $4,954,000 | 3.22% |
Bain Capital Life Sciences Investors, LLC | 5,385,667 | $33,499,000 | 2.66% |
Sarissa Capital Management LP | 4,299,297 | $26,742,000 | 2.32% |
Avoro Capital Advisors LLC | 6,800,000 | $42,296,000 | 0.72% |
Rock Springs Capital Management LP | 3,248,950 | $20,208,000 | 0.47% |
Bellevue Group AG | 4,164,000 | $25,900,000 | 0.27% |
Orbimed Advisors | 2,888,847 | $17,969,000 | 0.23% |
DAFNA Capital Management LLC | 140,263 | $872,000 | 0.22% |
Artal Group S.A. | 1,200,000 | $7,464,000 | 0.20% |
Bridgefront Capital, LLC | 15,622 | $97,000 | 0.09% |